Back to 
ProShare Advisors LLC
ProShare Advisors LLC
INBXShowing 0 of 6 quarters
Position history for ProShare Advisors LLC's holdings in Inhibrx Biosciences, Inc.
As of its Q1 2024 13F, ProShare Advisors held 16,741 shares of INBX (Inhibrx Biosciences), worth $585,266. ProShare Advisors' 13F filings listed INBX from Q4 2023 to Q1 2024, 2 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of INBX: Viking Global Investors LP, RA Capital Management, L.P.